Futura Medical (LON:FUM) Stock Price Down 9.7% – Should You Sell?

Futura Medical plc (LON:FUM)’s stock price was down 9.7% during trading on Tuesday . The company traded as low as GBX 0.24 and last traded at GBX 0.50. Approximately 7,041,876 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 8,535,829 shares. The stock had previously closed at GBX 0.55.

Futura Medical Stock Down 9.7%

The company has a 50 day simple moving average of GBX 0.69 and a two-hundred day simple moving average of GBX 1.04. The company has a market capitalization of £2.91 million, a P/E ratio of -0.18 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The company had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. As a group, research analysts expect that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.